Contract Manufacturing News: Breaking Contract Manufacturing News, Comments and Articles. - Page: 4

NextPharma completes executive management team with the appointment of Jean Cuiné as Chief Scientific Officer

NextPharma Technologies Holding Limited, one of the leading contract manufacturers in Europe for the pharmaceutical, biotechnology and healthcare industries, is delighted to announce the appointment of Jean Cuiné to its executive management team. Dr Cuiné has joined NextPharma from Novartis where he held a number of senior roles in Chemistry Manufacturin...

The World Small Animal Veterinary Association Recommends Canine VacciCheck

KIBBUTZ GALED, Israel, May 16, 2013 /PRNewswire/ -- The World Small Animal Veterinary Association (WSAVA) Vaccination Guidelines Group has recently published the "Vaccination Guidelines for New Puppy Owners". The guidelines' aim is to ensure that dogs are protected from infectious disease, while reducing the number of vaccines that are given routinely. As part of this aim, the WSAVA Vaccinating...

Access Pharmaceuticals Reports First Quarter Results

DALLAS and NEW YORK, May 16, 2013 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, released its first quarter ended March 31, 2013 financial results.  The company indicated it will host a conference call at a later date to review financial results and ongoing commercial MuGard progress made within the quarter.  MuGard, Access' lead p...

Source BioScience Interim Management Statement

16th May 2013: Source BioScience plc (LSE: SBS), the international diagnostic and genetic analysis services business, today publishes its Interim Management Statement for the year to date. Unless otherwise stated, the financial information referenced below refers to the four months ended 30 April 2013, and the corresponding period last year, this being the latest practicable date to which f...

TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events

BETHESDA, Md., May 16, 2013 /PRNewswire/ -- TNI BioTech, Inc.,  (OTC PINK: TNIB), a biotech company combating fatal diseases through the activation and mobilization of the body's immune system using its patented immunotherapy, issued a letter to its shareholders from CEO Noreen Griffin and the company's board of directors. The letter follows: Dear Shareholders, The board of direct...

AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin Antibodies

SAN DIEGO, May 16, 2013 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the receipt of a contract award from the U.S. government for the development of highly thermostable anti-ricin antibodies for biodefense applications.  Under the terms of AnaptysBio's contract with the Science and Technology Corporation, AnaptysBio will be responsible...

Bavarian Nordic - Interim Financial Report for the Period 1 January to 31 March 2013

KVISTGAARD, Denmark, May 16, 2013 - Bavarian Nordic A/S (OMX: BAVA) today publishes its first quarter 2013 results. Revenue for the period was DKK 206 million (2012: DKK 168 million) and the result before tax was a loss of DKK 41 million (2012: DKK 35 million loss). The Infectious Disease division remains profitable with an EBIT of DKK 38 million in the period (2012: DKK 47 million). After receiv...

New Study: Oral Sex Linked to Throat Cancer; polyDNA Recommends Gene-Eden-VIR against HPV, the Virus Associated with Throat Cancer

92.6% of patients with throat cancer also had an HPV infection, according to a new paper published in April, 2013 from the American Journal of Gastroenterology. (1) polyDNA suggests taking Gene-Eden-VIR to kill latent HPV in the throat. Rochester, NY (PRWEB) May 16, 2013 A new study shows more friends with benefits is not always better. The study found a link between the number of oral sex partne...

Pharming reports on financial results first quarter 2013

Leiden, The Netherlands, 16 May 2013. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today published its financial report for the three months ended 31 March 2013. FINANCIAL HIGHLIGHTS Revenues and other income decreased to €0.5 million (Q1 2012: €1.0 million) Operating costs decreased to €2.9 million (Q1 2012: €5.2 million...

Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013

Dr. Stephen Y. Chou, Founder of Nanonex Corporation, will be giving a tutorial titled “Nanoimprint Lithography and Applications” at IEEE Nano 2013 in Beijing, China, on August 5th 2013. (PRWEB) May 16, 2013 Dr. Stephen Y. Chou, Founder of Nanonex Corporation, will be giving a tutorial titled “Nanoimprint Lithography and Applications” at IEEE Nano 2013 in Beijing, China, on August 5th 2013...

Lung Cancer Asbestos Victims Center Urges Victims Of Mesothelioma Or Asbestos Exposure Lung Cancer To Call Them For The Names Of The Nation's Leading Lawyers-Compensation

The Lung Cancer Asbestos Victims Center is now urging all diagnosed victims of mesothelioma, or victims of any type of lung cancer, who were exposed to asbestos at work to call them about possible significant financial compensation, and the names, and specific contacts for the leading mesothelioma, or asbestos exposure law firms in the nation, because the best mesothelioma law firms, get the best...

Mesothelioma Victims Center Urges Victims Of Mesothelioma Who Worked In Manufacturing To Call Them For Instant Access To The Most Skilled Lawyers-Get Much Better Results

The Mesothelioma Victims Center is urging diagnosed victims of mesothelioma, or their family members to call them for instant access to the nation's most experienced, and skilled mesothelioma lawyers, because mesothelioma compensation claims frequently exceed a million dollars for manufacturing, or industrial workers, and the law firms, or specific lawyers the group recommends to the victim, o...

Dialysis Equipment Manufacturing in the US Industry Market Research Report Now Available from IBISWorld

An aging population will ensure demand for dialysis treatment over the next five years, and a recovered economy will encourage the replacement of new dialysis equipment. For these reasons, industry research firm IBISWorld has added a report on the Dialysis Equipment Manufacturing industry to its growing industry report collection. Los Angeles, CA (PRWEB) May 16, 2013 Despite growing demand for di...

Liquid Health, Inc. Announces the Winner of their Prenatal Vitamin Giveaway

To promote their new prenatal vitamin, Liquid Health, Inc. recently held a contest to give away a 9-month supply of the product. The winner, Carie A. of Port Orchard, WA, was randomly chosen on Friday, May 10, 2013. Murrieta, CA (PRWEB) May 16, 2013 In an effort to generate excitement about their new product, Liquid Health, Inc. held a giveaway in conjunction with the release of the Liquid Prena...

Nordion, Navidea sign contract manufacturing agreement

Nordion has entered into a contract manufacturing agreement with Navidea Biopharmaceuticals for NAV5001 a diagnostic imaging agent used to detect Parkinsonian Syndromes and Dementia with Lewy Bodies.

Amgen-Zhejiang Beta China JV to Include R&D, Manufacturing

Last week, Amgen and Zhejiang Beta Pharma announced they would form a JV to bring Amgen’s biologic drugs to China, starting with Amgen’s colon cancer drug Vectibix. Now, an Amgen spokesperson told China Daily the JV will include a China-b...

Helsinn Group and Eisai Inc. Announce Top-Line Results for Pivotal Studies of the Investigational Fixed-Dose Combination of Netupitant and Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting

LUGANO, Switzerland and WOODCLIFF LAKE, N.J., May 16, 2013 /PRNewswire/ -- Helsinn Group and Eisai Inc. announced today top-line results from Helsinn's pivotal clinical studies investigating the oral fixed-dose combination of netupitant and palonosetron (NEPA) being evaluated for the proposed indication of prevention of chemotherapy-induced nausea and vomiting (CINV).  These data will be...

Alkaline Ionized Water Treatment for Cancer is Examined in Today’s Bawell Water Ionizer Health News Report

Today, the Bawell Water Ionizer Health News published information from the Independent Cancer Research Foundation about the positive effects of alkaline ionized drinking water when used for treating cancer. Boca Raton, FL (PRWEB) May 15, 2013 Drinking alkaline ionized water to treat cancer is covered in the Bawell Water Ionizer Health News report that was published earlier today. The health news...

California Physician Groups Congratulate Marilyn Tavenner on Her Confirmation

California Association of Physician Groups: Statement from Donald CranePresident and CEOCalifornia Association of Physician Groups “The California Association of Physician Groups (CAPG) congratulates Marilyn Tavenner on her Senate Confirmation as CMS Administrator. CAPG and its members look forward to continuing to work with Ms. Tavenne...

Response Genetics, Inc. Announces Contract With Blue Shield of California

LOS ANGELES, May 16, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced that it has entered into an agreement with health insurer Blue Shield of California to join all of Blue Shield of California's provider networks. The agreement...

DRC Reports Extension of Veterans Relationship Management Contract

ANDOVER, Mass., May 16, 2013 (GLOBE NEWSWIRE) -- Dynamics Research Corporation (Nasdaq:DRCO), a leading technology and management consulting company focused on driving performance, process and results for government clients, today reported that the Department of Veterans Affairs (VA), through the General Services Administration, has exercised the third option year of the Veterans Relationship Man...

Chembio Enters Into Six-Month Follow-On Contract With CDC Contractor for Development of Rapid, Point-of-Care Influenza Immunity Test

MEDFORD, N.Y., May 16, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, announces that the Company has entered into a follow-on, milestone-based development agreement with a private contracting organization that is engaged to enter into, implement and provide technical oversight of agreements relating to pa...

Conference Tackles Role of Biotherapeutic Drugs and Biosimilars, Harmonization of Regulatory Standards

Conference focuses on challenges in manufacturing biotherapeutics, evaluation and registration of biotherapeutic and biosimilar products, immunogenicity and safety monitoring, interchangeability, and pharmacovigilance.

Nordion, Navidea Sign Manufacturing Contract

Will cover manufacture and supply of diagnostic imaging agent for trials

Sexy and Bold “Dogma” Thigh-High Sandals from Haus Von Lila® are Headed for the US Designer Footwear Market

Following its smash hit debut at the recent Magic Shoe Exhibition in Las Vegas, the show-stopping thigh-high “Dogma” sandal design by Haus Von Lila™ has completed its first production run and is now headed for the US shoe market. Winnie Peng of http://www.Shoe-Manufacturer.com advises savvy designer-shoe collectors to reserve their pair of Dogma from Haus Von Lila® as this first shipmen...